Almirall (Almirall) Days Inventory : 483.63 (As of Jun. 2023)

View and export this data going back to . Start your Free Trial

What is Almirall Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Almirall's Average Total Inventories for the three months ended in Jun. 2023 was $149.7 Mil. Almirall's Cost of Goods Sold for the three months ended in Jun. 2023 was $28.2 Mil. Hence, Almirall's Days Inventory for the three months ended in Jun. 2023 was 483.63.

The historical rank and industry rank for Almirall's Days Inventory or its related term are showing as below:

LBTSF' s Days Inventory Range Over the Past 10 Years
Min: 183.42 Med: 201.64 Max: 493.49
Current: 493.49

During the past 13 years, Almirall's highest Days Inventory was 493.49. The lowest was 183.42. And the median was 201.64.

LBTSF's Days Inventory is ranked worse than
94.14% of 973 companies
in the Drug Manufacturers industry
Industry Median: 157.54 vs LBTSF: 493.49

Almirall's Days Inventory increased from Mar. 2022 (152.36) to Jun. 2023 (483.63). It might indicate that Almirall's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Almirall's Inventory Turnover for the three months ended in Jun. 2023 was 0.19.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Almirall's Inventory-to-Revenue for the three months ended in Jun. 2023 was 0.59.

Almirall Days Inventory Historical Data

The historical data trend for Almirall's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Almirall Days Inventory Chart

Almirall Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Inventory

Get a 7-Day Free Trial

196.27

238.78

274.95

233.86

252.18

Almirall Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Mar23	Jun23	Dec23
Days Inventory	Get a 7-Day Free Trial															599.24	-	149.53	483.63	-

Competitive Comparison of Almirall's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Almirall's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Almirall's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Almirall's Days Inventory distribution charts can be found below:

* The bar in red indicates where Almirall's Days Inventory falls into.

Almirall Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Almirall's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as

	Days Inventory (A: Dec. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2022 )	+	Total Inventories (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (137.657	+	182.519)	/	2 )	/	231.711	*	365
=	160.088					/	231.711	*	365
=	252.18

Almirall's Days Inventory for the quarter that ended in Jun. 2023 is calculated as:

	Days Inventory (Q: Jun. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Mar. 2023 )	+	Total Inventories (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (144.111	+	155.33)	/	2 )	/	28.249	*	365 / 4
=	149.7205					/	28.249	*	365 / 4
=	483.63

Almirall (OTCPK:LBTSF) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Almirall's Inventory Turnover for the three months ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	28.249	/	149.7205
	=	0.19

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Almirall's Inventory to Revenue for the three months ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	149.7205	/	254.315
	=	0.59

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Almirall Days Inventory Related Terms

Thank you for viewing the detailed overview of Almirall's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Almirall (Almirall) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Almirall SA (OTCPK:LBTSF) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

0O9B:UK ALM:Spain E2Z:Germany

Address

Ronda General Mitre 151, Barcelona, ESP, 08022

Website

http://www.almirall.es

Almirall SA is a Spain-based company engaged in development, manufacture, and selling pharmaceutical products across a range of therapeutic areas. It aims to provide treatments in areas of dermatology, respiratory, gastrointestinal, central nervous systems, and other specialties. The company operates in five segments: Sales of its own network, sales of licensees, Research and developments, Sales of Therapeutic dermatological products in the U.S., and Corporate management. The medical dermatology business in the Europe is the key driver of the company's operation. Other than Europe, the company also operates in the Americas, Asia, Africa, and Oceania through subsidiaries.